Xin Feng | Health Professions | Best Researcher Award

Prof Dr. Xin Feng | Health Professions | Best Researcher Award

Qilu hospital of Shandong University | China

Author Profile

Scopus

Orcid

Early Academic Pursuits

Prof. Dr. Xin Feng began his academic journey at Shandong University, where he pursued medical and doctoral degrees. His passion for otolaryngology led him to undertake post-doctoral training at the Asthma and Allergic Diseases Center, University of Virginia, where he honed his expertise in rhinologic diseases and allergies.

Professional Endeavors

As Deputy Director of the Department of Otorhinolaryngology at Qilu Hospital of Shandong University and Deputy Director of the National Health Commission (NHC) Key Laboratory of Otorhinolaryngology, Prof. Dr. Xin Feng has played pivotal roles in advancing research and clinical practice in his field. He has also served in leadership positions in various medical associations, including the Otolaryngology Head and Neck Surgery Branch of the Chinese Medical Association.

Contributions and Research Focus

Prof. Dr. Xin Feng's research encompasses a wide range of topics, including nasal polys and asthma, chronic rhinosinusitis, and allergic rhinitis. He has been the principal investigator for several prestigious research programs, focusing on elucidating the pathogenesis of rhinologic diseases and exploring innovative treatment modalities.

Accolades and Recognition

Prof. Dr. Xin Feng's contributions to the field of otolaryngology have been recognized with numerous awards and honors, including the Taishan Scholar Program, Outstanding Young Doctor Prize of Shandong Province, and the New Technology Award of Shandong Medical Association. His outstanding scientific research achievements have earned him accolades from both national and international medical communities.

Impact and Influence

Through his extensive publications in renowned journals such as J Allergy Clin Immunol and Am J Respir Cell Mol Biol, Prof. Dr. Xin Feng has significantly contributed to advancing the understanding of rhinologic diseases and allergic conditions. His research findings have not only enhanced clinical management strategies but also paved the way for the development of novel diagnostic tools and therapeutic interventions.

Legacy and Future Contributions

Prof. Dr. Xin Feng's legacy in otolaryngology and allergy research is characterized by his unwavering commitment to improving patient outcomes and advancing medical knowledge. His future contributions are anticipated to further deepen our understanding of rhinologic diseases and allergic conditions, ultimately leading to better treatment options and improved quality of life for patients worldwide.

Notable Publications

Deep learning radiomics-based preoperative prediction of recurrence in chronic rhinosinusitis 2023 (3)

Expression Profiles of Matrix Metalloproteinases and Their Inhibitors in Nasal Polyps 2024

Transcriptomic analysis of asthma and allergic rhinitis reveals CST1 as a biomarker of unified airways 2023 (7)

Identification of key genes and pathways in chronic rhinosinusitis with nasal polyps and asthma comorbidity using bioinformatics approaches 2022 (6)

Improvement of Subjective Olfactory Dysfunction in Chronic Rhinosinusitis With Nasal Polyps After Endoscopic Sinus Surgery 2022 (2)

 

Sanita Maleskic Kapo | Medicine and Dentistry | Best Researcher Award

Dr. Sanita Maleskic Kapo | Medicine and Dentistry | Best Researcher Award

University of Sarajevo | Bosnia and Herzegovina

Author Profile

Google Scholar

Early Academic Pursuits

Sanita Maleskic Kapo began her academic journey at the University of Sarajevo, delving into Pharmacology, Clinical Pharmacology, and Toxicology, culminating in her medical doctorate. Her formative years as a general practitioner at the Primary Health Care Center in Bihać enriched her understanding of patient care and community health.

Professional Endeavors

Transitioning into academia, she embraced teaching roles at the Faculty of Medicine, Sarajevo. Starting as a teaching assistant, her dedication and expertise elevated her to the position of Senior Teaching Assistant. Simultaneously, she embarked on a journey towards a Ph.D. in Pharmacology, further deepening her scholarly pursuits. Additionally, her ongoing residency in Clinical Pharmacology amplifies her practical acumen in the field.

Contributions and Research Focus

Sanita's contributions extend across academia and clinical practice. Her research focus in Pharmacology and Clinical Toxicology underscores her commitment to advancing medical knowledge. This commitment is reflected in her concurrent pursuit of a Ph.D. and residency, showcasing a dedication to scholarly and practical excellence.

Accolades and Recognition

Sanita Maleskic Kapo's journey is enriched by her notable accomplishments and dedication, marking her as a standout professional. While specific accolades may not be explicitly outlined, her multifaceted roles and continued academic progression underscore her recognition within the academic and medical spheres.

Impact and Influence

Her impact resonates through her teaching engagements, shaping future medical professionals. Simultaneously, her research endeavors lay the groundwork for advancements in Pharmacology and Clinical Toxicology, potentially influencing medical practices and patient care.

Legacy and Future Contributions

Sanita's legacy lies in her multifaceted contributions to academia, clinical research, and patient care. Her continued pursuit of a Ph.D. and residency promises a future where her expertise will further illuminate the realms of Pharmacology and Clinical Toxicology, potentially leaving an indelible mark in the field.

Notable Publications

Metformin use associated with protective effects for ocular complications in patients with type 2 diabetes - observational study 2017 (27)

Bioanthropological analysis of human occipital condyles using geometric morphometric method 2020 (5)

Analysis of gender differences on pyriform aperture of human skulls using geometric morphometric method 2021 (5)

Effects of topically applied diclofenac and ketoprofen on prostaglandin E2 and Stat3 sera levels and body temperature in two different acute inflammation models in rats 2021 (2)

Evaluation of long-term efficacy of disease-modifying agents in patients with relapsing-remitting multiple sclerosis 2019 (1)